Abstract
During the course of infection with a hemorrhagic fever virus (HFV), the checks and balances associated with normal coagulation are perturbed resulting in hemorrhage in severe cases and, in some patients, disseminated intravascular coagulopathy (DIC). While many HFVs have animal models that permit the analyses of systemic coagulopathy, animal infection models do not exist for all HFVs and moreover do not always recapitulate the pathology observed in human tissues. Furthermore, molecular analyses of how coagulation is affected are not always straightforward or practical when using ex-vivo animal-derived samples, thus reinforcing the importance of cell culture studies. This chapter highlights procedures utilizing human umbilical vein endothelial cells (HUVECs) as a model system to evaluate components of the intrinsic (prekallikrein (PK), factor XII (FXII), kininogen, and bradykinin (BK)) and extrinsic (Tissue Factor (TF)) systems. Specifically, protocols are included for the generation of a coculture blood vessel model, plating and infection of HUVEC monolayers and assays designed to measure activation of PK and FXII, cleavage of kininogen, and to measure the expression of TF mRNA and protein.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Paessler S, Walker DH (2013) Pathogenesis of the viral hemorrhagic fevers. Annu Rev Pathol 8:411–440. doi:10.1146/annurev-pathol-020712-164041
Centers for Disease Control and Prevention. Special Pathogens Branch. (2013) Viral hemorrhagic fevers. http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/vhf.htm
Versteeg HH, Heemskerk JW, Levi M, Reitsma PH (2013) New fundamentals in hemostasis. Physiol Rev 93:327–358. doi:10.1152/physrev.00016.2011
Sosothikul D, Seksarn P, Pongsewalak S, Thisyakorn U, Lusher J (2007) Activation of endothelial cells, coagulation and fibrinolysis in children with dengue virus infection. Thromb Haemost 97:627–634
Geisbert TW, Hensley LE, Jahrling PB, Larsen T, Geisbert JB, Paragas J, Young HA, Fredeking TM, Rote WE, Vlasuk GP (2003) Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. Lancet 362:1953–1958. doi:10.1016/S0140-6736(03)15012-XS0140-6736(03)15012-X [pii]
Geisbert TW, Young HA, Jahrling PB, Davis KJ, Kagan E, Hensley LE (2003) Mechanisms underlying coagulation abnormalities in Ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J Infect Dis 188:1618–1629. doi:10.1086/379724JID30697 [pii]
National Library of Medicine (2012) vWF Genetics Home Reference U.S. National Library of Medicine. http://ghr.nlm.nih.gov/gene/VWF
Adams RL, Bird RJ (2009) Review article: coagulation cascade and therapeutics update: relevance to nephrology. Part 1: overview of coagulation, thrombophilias and history of anticoagulants. Nephrology (Carlton) 14:462–470. doi: NEP1128 [pii] 1111/j.1440-1797.2009.01128.x]
Schattner M, Rivadeneyra L, Pozner RG, Gomez RM (2013) Pathogenic mechanisms involved in the hematological alterations of arenavirus-induced hemorrhagic fevers. Viruses 5:340–351. doi:10.3390/v5010340
Taylor SL, Wahl-Jensen V, Copeland AM, Jahrling PB, Schmaljohn CS (2013) Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the Kallikrein-Kinin system. PLoS Pathog 9:e1003470. doi:10.1371/journal.ppat.1003470. PPATHOGENS-D-13-00307 [pii]
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Tursiella, M.L., Taylor, S.L., Schmaljohn, C.S. (2018). Protocols to Assess Coagulation Following In Vitro Infection with Hemorrhagic Fever Viruses. In: Salvato, M. (eds) Hemorrhagic Fever Viruses. Methods in Molecular Biology, vol 1604. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6981-4_30
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6981-4_30
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6980-7
Online ISBN: 978-1-4939-6981-4
eBook Packages: Springer Protocols